Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28473264 | 0.85 | NPC1 (0.42) | NPC1MAPTALDH1A1LMNAGAA | |
| SCHEMBL28474461 | 0.83 | MAPT (0.56) | MAPTALDH1A1LMNASMN1; SMN2GAA | |
| SCHEMBL28485410 | 0.82 | NPC1 (0.46) | NPC1MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL28474493 | 0.79 | HTT (0.47) | ALDH1A1SMN1; SMN2HTTMEN1KMT2A | |
| SCHEMBL28480715 | 0.75 | KMT2A (0.47) | ALDH1A1LMNASMN1; SMN2HTTPKM | |
| SCHEMBL25619979 | 0.75 | L3MBTL1 (0.41) | NPC1MAPTALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL28901016 | 0.75 | L3MBTL1 (0.46) | ALDH1A1LMNASMN1; SMN2HTTPKM | |
| SCHEMBL28485993 | 0.74 | LMNA (0.44) | MAPTALDH1A1LMNASMN1; SMN2HTT | |
| SCHEMBL21410465 | 0.73 | NPC1 (0.40) | NPC1MAPTALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL28472330 | 0.72 | LMNA (0.43) | ALDH1A1LMNASMN1; SMN2HTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111918864-A | Prodrug compounds activated by AKR1C3 and their use to treat hyperproliferative disorders | 阿基利斯医疗有限公司 | 2020-11-10 | — | — | CN | claimed |
| CN-111918864-A | Prodrug compounds activated by AKR1C3 and their use to treat hyperproliferative disorders | 阿基利斯医疗有限公司 | 2020-11-10 | — | — | CN | disclosed |